Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

<div>Kaplan–Meier curves of (i) overall survival and (ii) relapse-free survival stratified by GR IHC expression in the cohorts: (a) TMA #3 CMF treated (<i>N</i> = 77), (b) TMA #3 taxane treated (<i>N</i> = 18), (c) TMA #4 all chemo (<i>N</i> = 62), and (d) TMA #4 anthracycline treated (<i>N</i> = 41).</div>

Journal of Oncology

fig5

Figure 5

Figure 5: Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer 

Figure 5 | Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer 